PCV19 RESIDUAL DYSLIPIDEMIA ON SIMVASTATIN- POPULATION MODELING OF OPTIMAL LIPID VALUE ACHIEVEMENT WITH ADDED EXTENDED-RELEASE NIACIN VERSUS EZETIMIBE
Abstract
Authors
E Stanek S Charland
E Stanek S Charland
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now